Literature DB >> 1625684

Serum lipids and urinary albumin excretion in non insulin-dependent diabetics.

S Suraniti1, F Bled, A Girault, P Fressinaud, M Marre.   

Abstract

The increase of urinary albumin excretion has a predictive value for cardiovascular disease in insulin-dependent and non insulin-dependent diabetics. To study the relationship between urinary albumin excretion and serum lipids, 380 non insulin-dependent diabetics, 40 to 75 yr old, with urinary albumin excretion from 0 to 200 mg/l, and normal serum creatinine (less than 150 mumol/l), were surveyed. Urinary albumin excretion, was related positively to age (r2 = 0.014; p = 0.02), to systolic blood pressure (r2 = 0.073, p = 0.0001) and diastolic blood pressure (r2 = 0.052, p = 0.0001); a negative correlation existed with HDL-cholesterol (r2 = 0.043, p = 0.0001) and Apoprotein A1 (r2 = 0.044, p = 0.0001). A stepwise regression analysis was performed and resulted in three independently contributing variables related to urinary albumin excretion: First systolic blood pressure (F = 36), second Apoprotein A1 (F 24), third hemoglobin A1C (F = 6). The presence of hypertension or insulin therapy did not modify these findings. In conclusion, serum lipid seems an important determinant of urinary albumin excretion in non insulin-dependent diabetics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1625684     DOI: 10.1007/bf00229777

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  10 in total

1.  Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients.

Authors:  M B Mattock; H Keen; G C Viberti; M R el-Gohari; T J Murrells; G S Scott; J R Wing; P G Jackson
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

2.  Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.

Authors:  J S Yudkin; R D Forrest; C A Jackson
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

3.  Laser immunonephelometry for routine quantification of urinary albumin excretion.

Authors:  M Marre; J P Claudel; P Ciret; N Luis; L Suarez; P Passa
Journal:  Clin Chem       Date:  1987-02       Impact factor: 8.327

4.  Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey.

Authors:  M P Stern; J K Patterson; S M Haffner; H P Hazuda; B D Mitchell
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

5.  Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.

Authors:  J Joven; C Villabona; E Vilella; L Masana; R Albertí; M Vallés
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

6.  Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus.

Authors:  G C Viberti; R D Hill; R J Jarrett; A Argyropoulos; U Mahmud; H Keen
Journal:  Lancet       Date:  1982-06-26       Impact factor: 79.321

7.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

Authors:  T Jensen; S Stender; T Deckert
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

8.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

Authors:  C E Mogensen
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

9.  Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors.

Authors:  T Jensen; K Borch-Johnsen; A Kofoed-Enevoldsen; T Deckert
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

10.  Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.

Authors:  S L Jones; C F Close; M B Mattock; R J Jarrett; H Keen; G C Viberti
Journal:  BMJ       Date:  1989-02-25
  10 in total
  1 in total

Review 1.  Enhancing insulin action: from chemical elements to thiazolidinediones.

Authors:  R Perfetti; K Chamie
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.